Liquid biopsies and cancer omics.
Liquid biopsies and cancer omics.
复制标题
DOI:
10.1038/s41420-020-00373-0
复制
发表时间:
2020-11-26
影响因子:
7
通讯作者:
Melino G
中科院分区:
文献类型:
--
作者:
Amelio I;Bertolo R;Bove P;Buonomo OC;Candi E;Chiocchi M;Cipriani C;Di Daniele N;Ganini C;Juhl H;Mauriello A;Marani C;Marshall J;Montanaro M;Palmieri G;Piacentini M;Sica G;Tesauro M;Rovella V;Tisone G;Shi Y;Wang Y;Melino G
The development of the sequencing technologies allowed the generation of huge amounts of molecular data from a single cancer specimen, allowing the clinical oncology to enter the era of the precision medicine. This massive amount of data is highlighting new details on cancer pathogenesis but still relies on tissue biopsies, which are unable to capture the dynamic nature of cancer through its evolution. This assumption led to the exploration of non-tissue sources of tumoral material opening the field of liquid biopsies. Blood, together with body fluids such as urines, or stool, from cancer patients, are analyzed applying the techniques used for the generation of omics data. With blood, this approach would allow to take into account tumor heterogeneity (since the circulating components such as CTCs, ctDNA, or ECVs derive from each cancer clone) in a time dependent manner, resulting in a somehow “real-time” understanding of cancer evolution. Liquid biopsies are beginning nowdays to be applied in many cancer contexts and are at the basis of many clinical trials in oncology.
登录
查看更多内容
影响因子:
3.2
作者:
Combaret, Valerie;Hogarty, Michael D.;Puisieux, Alain
通讯作者:
Puisieux, Alain
影响因子:
12.4
作者:
通讯作者:
--
DOI:
10.1073/pnas.0507904102
发表时间:
2005-11-08
影响因子:
11.1
作者:
Diehl, F;Li, M;Vogelstein, B
通讯作者:
Vogelstein, B
影响因子:
2.7
作者:
Ankney, J. Astor;Xie, Ling;Chen, Xian
通讯作者:
Chen, Xian
影响因子:
4
作者:
Combaret, Valerie;Iacono, Isabelle;Bellini, Angela;Brejon, Stephanie;Bernard, Virginie;Marabelle, Aurelien;Coze, Carole;Pierron, Gaelle;Lapouble, Eve;Schleiermacher, Gudrun;Blay, Jean Yves
通讯作者:
Blay, Jean Yves